Auvi-q and Drowsiness - a phase IV clinical study of FDA data

Summary:

Drowsiness is reported as a side effect among people who take Auvi-q (epinephrine), especially for people who are female, 10-19 old, have been taking the drug for < 1 month also take Proair Hfa, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Drowsiness when taking Auvi-q. It is created by eHealthMe based on reports of 878 people who have side effects when taking Auvi-q from the FDA, and is updated regularly.

What is Auvi-q?

Auvi-q has active ingredients of epinephrine. eHealthMe is studying from 878 Auvi-q users. Check the latest studies of Auvi-q.

What is Drowsiness?

Drowsiness is found to be associated with 2,865 drugs and 4,797 conditions by eHealthMe. Check the latest studies of Drowsiness.

On Jul, 19, 2026

878 people reported to have side effects when taking Auvi-q.
Among them, 12 people (1.37%) have Drowsiness.

Among these 12 people:

How long have people been on Auvi-q when they have Drowsiness? *

What is the gender of people who have Drowsiness when taking Auvi-q? *

female: 75 %
male: 25 %

What is the age of people who have Drowsiness when taking Auvi-q? *

What are other drugs people take besides Auvi-q? *

What are other side effects people have besides Drowsiness? *

Drug Hypersensitivity: 6 people, 50.00%
Skin Ulcer: 6 people, 50.00%
Abdominal Pain: 5 people, 41.67%
Psoriasis (immune-mediated disease that affects the skin): 5 people, 41.67%
Blood Immunoglobulin A Decreased: 5 people, 41.67%
Diabetic Foot: 5 people, 41.67%
Hyperhidrosis (abnormally increased sweating): 5 people, 41.67%
Kidney Infection: 5 people, 41.67%
White Blood Cell Count Increased: 5 people, 41.67%
Migraine (headache): 5 people, 41.67%

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 6 people, 50.00%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 8.33%
Hypersensitivity: 1 person, 8.33%
Food Allergy: 1 person, 8.33%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 8.33%
Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Auvi-q and have Drowsiness?

- Check whether Drowsiness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Auvi-q:

Auvi-q (878 reports)

Drowsiness treatments and more:

Drowsiness (269,040 reports)

Browse all side effects of Auvi-q:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Drowsiness:

Drowsiness (2,865 drugs)

Browse all the conditions that are associated with Drowsiness:

Drowsiness (4,797 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on epinephrine (the active ingredients of Auvi-q) and Auvi-q (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.